Financhill
Buy
78

CX Quote, Financials, Valuation and Earnings

Last price:
$5.69
Seasonality move :
3.8%
Day range:
$5.57 - $5.66
52-week range:
$5.00 - $9.27
Dividend yield:
1.1%
P/E ratio:
19.03x
P/S ratio:
0.48x
P/B ratio:
0.68x
Volume:
2.2M
Avg. volume:
9.5M
1-year change:
-31.06%
Market cap:
$8.2B
Revenue:
$17.4B
EPS (TTM):
$0.30

Earnings Data

Next earnings date for CX
Feb 07
2025
Most recent earnings per share
$0.27
Missed by $0.14
(Oct 28/2024)
Consensus Estimate
$0.40
(Oct 28/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/07/2025 Q4 $4B -- -- $0.31 --
10/28/2024 Q3 $4.3B $4.1B $0.27 $0.40 -$0.14
07/25/2024 Q2 $4.6B $4.5B $0.16 $0.25 -$0.09
04/25/2024 Q1 $4.1B $4.1B $0.17 $0.19 -$0.02
02/08/2024 Q4 $4.3B $4.9B -$0.30 $0.19 -$0.49
10/26/2023 Q3 -- -- $0.09 $0.21 -$0.12
07/27/2023 Q2 -- -- $0.18 $0.19 -$0.01
05/02/2023 Q1 -- -- $0.15 $0.12 $0.03
02/13/2023 Q4 -- -- -$0.07 $0.14 -$0.21
10/27/2022 Q3 -- -- $10.20 $0.18 $10.02
07/28/2022 Q2 -- -- $0.18 $0.15 $0.03
06/27/2022 Q1 -- -- $0.14 $0.19 -$0.05
02/10/2022 Q4 -- -- $0.13 $0.16 -$0.03
10/28/2021 Q3 -- -- -$0.26 $0.21 -$0.47
07/29/2021 Q2 -- -- $0.16 $0.16 -$0.00
04/29/2021 Q1 -- -- $0.44 $0.04 $0.40
02/11/2021 Q4 -- -- $0.03 $0.04 -$0.01
10/28/2020 Q3 -- -- -$1.02 $0.05 -$1.07
09/04/2020 Q2 -- -- -$0.03 -$0.02 -$0.01
04/30/2020 Q1 -- -- $0.03 $0.03 $0.00
02/12/2020 Q4 -- -- -$0.16 $0.04 -$0.20
10/24/2019 Q3 -- -- $0.13 $0.14 -$0.01
07/25/2019 Q2 -- -- -- $0.13 --
04/25/2019 Q1 -- -- -- $0.08 --
02/07/2019 Q4 -- -- -- $0.11 --
10/25/2018 Q3 -- -- -- $0.15 --
07/26/2018 Q2 -- -- -- -- --
04/26/2018 Q1 -- -- -- -- --
02/08/2018 Q4 -- -- -- -- --
10/25/2017 Q3 -- -- -- -- --
07/26/2017 Q2 -- -- -- -- --
04/26/2017 Q1 -- -- -- -- --
02/09/2017 Q4 -- -- -- -- --
10/27/2016 Q3 -- -- -- -- --
07/27/2016 Q2 -- -- -- -- --
04/21/2016 Q1 -- -- -- -- --
02/04/2016 Q4 -- -- -- -- --
10/22/2015 Q3 -- -- -- -- --
07/22/2015 Q2 -- -- -- -- --
04/23/2015 Q1 -- -- -- -- --
02/05/2015 Q4 -- -- -- -- --

Cemex SAB de CV Earnings Questions

  • How Much did Cemex SAB de CV Generate in Revenue Last Quarter?

    Cemex SAB de CV reported $4.1B worth of top line sales in its most recent quarter.

  • Did Cemex SAB de CV Beat Earnings Last Quarter?

    Cemex SAB de CV announced earnings per share of $0.27 which represents a miss of analyst forecast a $0.40 per share.

  • Is Cemex SAB de CV Profitable?

    Cemex SAB de CV reported $1.3B that represents $0.88 per share over the last quarter.

  • What is the Analyst Consensus for Cemex SAB de CV EPS Next Year?

    Cemex SAB de CV's earnings are forecast to grow from $0.12 per share to $0.65 per share next year representing an increase of 458.27%.

  • When is Cemex SAB de CV's Earnings Date?

    Cemex SAB de CV's next earnings date is February 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 26

Power Solutions International [PSIX] is down 3.92% over the past day.

Buy
65
TSLL alert for Dec 26

Direxion Daily TSLA Bull 2X Shares [TSLL] is down 4.17% over the past day.

Buy
75
SMLR alert for Dec 26

Semler Scientific [SMLR] is down 2.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock